Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 1
1966 1
1967 3
1968 2
1973 1
1976 1
1977 3
1978 1
1979 3
1981 5
1982 2
1983 6
1984 5
1985 11
1986 7
1987 7
1988 10
1989 12
1990 11
1991 4
1992 14
1993 13
1994 8
1995 10
1996 5
1997 11
1998 11
1999 9
2000 6
2001 5
2002 11
2003 10
2004 12
2005 10
2006 11
2007 15
2008 16
2009 13
2010 14
2011 6
2012 8
2013 18
2014 14
2015 17
2016 12
2017 11
2018 18
2019 16
2020 22
2021 22
2022 20
2023 27
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

482 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for bende to
Search for Obende TO instead (2 results)
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):131-138. doi: 10.1016/S0140-6736(19)31150-X. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189509 Clinical Trial.
Heredity of nasal polyps.
Bohman A, Oscarsson M, Holmberg K, Johansson L, Millqvist E, Nasic S, Torinsson-Naluai Å, Bende M. Bohman A, et al. Rhinology. 2015 Mar;53(1):25-8. doi: 10.4193/Rhino14.032. Rhinology. 2015. PMID: 25756074
Nasal hyperreactivity to newspapers.
Theander C, Bende M. Theander C, et al. Clin Exp Allergy. 1989 Jan;19(1):57-8. doi: 10.1111/j.1365-2222.1989.tb02344.x. Clin Exp Allergy. 1989. PMID: 2702511
Evaluation of Prognostic Parameters to Identify Aggressive Penile Carcinomas.
Mink JN, Khalmurzaev O, Pryalukhin A, Geppert CI, Lohse S, Bende K, Lobo J, Henrique R, Loertzer H, Steffens J, Jerónimo C, Wunderlich H, Heinzelbecker J, Bohle RM, Stöckle M, Matveev V, Hartmann A, Junker K. Mink JN, et al. Cancers (Basel). 2023 Sep 27;15(19):4748. doi: 10.3390/cancers15194748. Cancers (Basel). 2023. PMID: 37835442 Free PMC article.
Erratum to: Olfactory dysfunction in chronic stroke patients.
Wehling E, Naess H, Wollschlaeger D, Hofstad H, Bramerson A, Bende M, Nordin S. Wehling E, et al. BMC Neurol. 2015 Nov 19;15:237. doi: 10.1186/s12883-015-0489-8. BMC Neurol. 2015. PMID: 26584820 Free PMC article. No abstract available.
482 results